Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001701247-26-000013 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 21, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
15,000
Total Value
$264,153.87
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | Sep 17, 2026 | Exercise/Conversion | 5,000 | $2.48 | $12,400.00 | 30,000 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Sep 17, 2026 | Sale | 2,916 | $50.03 | $145,890.98 | 27,084 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Sep 17, 2026 | Sale | 1,844 | $50.71 | $93,507.21 | 25,240 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Sep 17, 2026 | Sale | 240 | $51.48 | $12,355.68 | 25,000 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Stock Option (right to buy) | Derivative | Sep 17, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 106,268 | Direct | โ | View Details |